
Oravax and Genomma Lab Announce JV to Commercialize Oral COVID-19 Vaccine in Mexico and Latin America
Business Wire India Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical Inc Millions of people in the region could benefit